Source: Annual Congress 2003 - Airway problems and trauma
Disease area: Thoracic oncology



Rating:

Share or cite this content

Citations should be made in the following way:
A. D. Karanikolic, L. M. Stevanovic, M. Pesic, N. Djordjevic, M. A. Djordjevic (Nis, Paracin, Yugoslavia). Talc chemotherapeutic pleurodesis to palliate malignant pleural effusions secondary to breast cancer. Eur Respir J 2003; 22: Suppl. 45, 3184

Member's Comments

No comment yet.

Related content which might interest you: Thoracoscopy in malignant pleural effusions secondary to breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 611s Year: 2006 Efficacy of pleurodesis for malignant pleural effusions in breast cancer patients Source: Eur Respir J 2011; 38: 1425-1430 Year: 2011 Efficacious pleurodesis with OK-432 and doxorubicin against malignant pleural effusions Source: Eur Respir J 2004; 24: 263-266 Year: 2004 Videothoracoscopy in the treatment of malignant pleural effusions Source: Annual Congress 2009 - Pleural and mediastinal diseases Year: 2009 Talc pleurodesis in malignant pleural effusions Source: Eur Respir J 2001; 18: Suppl. 33, 386s Year: 2001 Efficacy of talc pleurodesis in patients with malignant pleural effusions Source: Annual Congress 2011 - Molecular markers: diagnosis and management of malignant pleural effusions Year: 2011 Chemotherapy for treatment of malignant pleural mesothelioma Source: Eur Respir J 2004; 24: Suppl. 48, 526s Year: 2004 Bevacizumab-targeted therapy for malignant pleural mesothelioma Source: International Congress 2017 – Malignant pleural effusion management in 2017: a review of recent RCTs Year: 2017 Hypotonic carboplatin pleurodesis for malignant pleural effusion of non-small cell lung cancer Source: Eur Respir J 2002; 20: Suppl. 38, 273s Year: 2002 Malignant pleural disease in primary lung cancer Source: Eur Respir Mon; 2009: 44: 318–335 Year: 2009 Efficacy of EGFR-TKI for malignant pleural effusion in lung adenocarcinoma patients Source: International Congress 2017 – Mesothelioma and malignant pleural disease Year: 2017 Pleurodesis in the treatment of malignant pleural effusion Source: Eur Respir J 2004; 24: Suppl. 48, 628s Year: 2004 Pleural effusion in lung cancer and targeted therapy Source: Hands-on Course 2013 - Medical Thoracoscopy Year: 2013 An update on treatment of malignant pleural effusion with or without known primary bronchial adenocarcinoma Source: Annual Congress 2006 - Medical and surgical management of malignant pleuritis Year: 2006 Predictors of successful pleurodesis for patients with malignant pleural effusions Source: Eur Respir J 2004; 24: Suppl. 48, 493s Year: 2004 Videothoracoscopy in diagnosis and palliative treatment of malignant pleural mesothelioma Source: Annual Congress 2008 - Biology and diagnosis of thoracic tumours Year: 2008 Thoracoscopic talc poudrage versus povidone-iodine for pleurodesis of effusion due to metastatic breast cancer Source: Eur Respir J 2006; 28: Suppl. 50, 754s Year: 2006 Talc mediates angiostasis in malignant pleural effusions via endostatin induction Source: Eur Respir J 2007; 29: 761-769 Year: 2007 Thoracoscopic palliative treatment of malignant pleural effusions Source: Annual Congress 2011 - A little bit of everything: interventional pneumology Year: 2011 Optimal treatment of pleurodesis for malignant pleural effusion in 2017 Source: ERS Skills course - Medical thoracoscopy Year: 2017